167 related articles for article (PubMed ID: 31941795)
1. Randomized controlled trial of
Todd JJ; Lawal TA; Witherspoon JW; Chrismer IC; Razaqyar MS; Punjabi M; Elliott JS; Tounkara F; Kuo A; Shelton MO; Allen C; Cosgrove MM; Linton M; Michael D; Jain MS; Waite M; Drinkard B; Wakim PG; Dowling JJ; Bönnemann CG; Emile-Backer M; Meilleur KG
Neurology; 2020 Mar; 94(13):e1434-e1444. PubMed ID: 31941795
[TBL] [Abstract][Full Text] [Related]
2. 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.
Witherspoon JW; Vasavada RP; Waite MR; Shelton M; Chrismer IC; Wakim PG; Jain MS; Bönnemann CG; Meilleur KG
Orphanet J Rare Dis; 2018 Jul; 13(1):105. PubMed ID: 29970108
[TBL] [Abstract][Full Text] [Related]
3. Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.
Capella-Peris C; Cosgrove MM; Chrismer IC; Razaqyar MS; Elliott JS; Kuo A; Emile-Backer M; Meilleur KG
Patient; 2020 Aug; 13(4):423-434. PubMed ID: 32329019
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.
Dowling JJ; Arbogast S; Hur J; Nelson DD; McEvoy A; Waugh T; Marty I; Lunardi J; Brooks SV; Kuwada JY; Ferreiro A
Brain; 2012 Apr; 135(Pt 4):1115-27. PubMed ID: 22418739
[TBL] [Abstract][Full Text] [Related]
5. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
Mol Autism; 2016; 7():26. PubMed ID: 27103982
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
[TBL] [Abstract][Full Text] [Related]
7. Reliability and Validity of Self-Report Questionnaires as Indicators of Fatigue in RYR1-Related Disorders.
Kuo A; Todd JJ; Witherspoon JW; Lawal TA; Elliott J; Chrismer IC; Shelton MO; Razaqyar MS; Jain MS; Vasavada R; Waite M; Drinkard B; Michael D; Richarte A; Bönnemann CG; Meilleur KG
J Neuromuscul Dis; 2019; 6(1):133-141. PubMed ID: 30714968
[TBL] [Abstract][Full Text] [Related]
8. Use of Fatigue Index as a Measure of Local Muscle Fatigability in Ryanodine Receptor Isoform-1-Related Myopathies.
Witherspoon JW; Rekant JS; Wakim PG; Vasavada R; Waite M; Chrismer I; Shelton MO; Jain MS; Meilleur KG
Front Neurol; 2019; 10():1234. PubMed ID: 31920904
[No Abstract] [Full Text] [Related]
9. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial.
Mahmoud KM; Ammar AS
Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168
[TBL] [Abstract][Full Text] [Related]
10. Production of 15-F
Kuhn MJ; Mavangira V; Gandy JC; Sordillo LM
J Dairy Sci; 2018 Oct; 101(10):9287-9295. PubMed ID: 30077444
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in children receiving valproic acid.
Michoulas A; Tong V; Teng XW; Chang TK; Abbott FS; Farrell K
J Pediatr; 2006 Nov; 149(5):692-6. PubMed ID: 17095346
[TBL] [Abstract][Full Text] [Related]
12. Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.
Capella-Peris C; Cosgrove MM; Chrismer IC; Emile-Backer M; Razaqyar MS; Elliott JS; Kuo A; Wakim PG; Meilleur KG
Qual Life Res; 2020 Jun; 29(6):1641-1653. PubMed ID: 32040747
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial.
Pattanakuhar S; Phrommintikul A; Tantiworawit A; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
Int J Med Sci; 2020; 17(9):1147-1155. PubMed ID: 32547310
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial.
Batooei M; Tahamoli-Roudsari A; Basiri Z; Yasrebifar F; Shahdoust M; Eshraghi A; Mehrpooya M; Ataei S
Rev Recent Clin Trials; 2018; 13(2):132-138. PubMed ID: 29521247
[TBL] [Abstract][Full Text] [Related]
15. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
17. Effect of N-acetylcysteine on cycling performance after intensified training.
Slattery KM; Dascombe B; Wallace LK; Bentley DJ; Coutts AJ
Med Sci Sports Exerc; 2014 Jun; 46(6):1114-23. PubMed ID: 24576857
[TBL] [Abstract][Full Text] [Related]
18. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
Molnar Z; Szakmany T; Koszegi T
Intensive Care Med; 2003 May; 29(5):749-55. PubMed ID: 12682719
[TBL] [Abstract][Full Text] [Related]
20. Benefits of high-dose N-acetylcysteine to exacerbation-prone patients with COPD.
Tse HN; Raiteri L; Wong KY; Ng LY; Yee KS; Tseng CZS
Chest; 2014 Sep; 146(3):611-623. PubMed ID: 24833327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
